Bangladesh is nearing a major milestone in public health as it approaches WHO Maturity Level 3 for vaccine regulation. This achievement, driven by the Directorate General of Drug Administration (DGDA), would signify that the country’s regulatory framework meets international standards for ensuring vaccine safety and efficacy.
The DGDA, as the national regulatory authority, has been working to strengthen oversight of drugs and vaccines. Public trust in Bangladesh’s vaccine system remains high, supported by rigorous regulatory processes.
Achieving Maturity Level 3 would not only bolster domestic confidence but also enhance Bangladesh’s role in global health security. It represents a significant step forward for the country’s healthcare infrastructure.
Article source: dailydhakatimes.com | Image credit: The Daily Star
